# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Tilray slips despite unveiling a licensed Panama JV to expand its medical cannabis footprint and clinician-focused access.
NEW YORK, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Tilray Medical ("Tilray"), a division of Tilray Brands, Inc. (NASDAQ:TLRY, ...
Tilray Brands shares are trading lower Friday morning, a sharp reversal after the stock hit a new 52-week high on Thursday.
https://www.sec.gov/Archives/edgar/data/1731348/000114036125037823/ny20056674x1_s3asr.htm
Tilray Brands shares are trading higher Thursday afternoon following the release of a strong first-quarter fiscal 2026 earnings...
Tilray stock surges after Q1 earnings beat estimates with break-even results, higher revenue, and improved balance sheet strength.